NRX Pharmaceuticals (NRXP) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

NRX Pharmaceuticals (NRXP) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

NRX Pharmaceuticals

· NRXP

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

126.424 M

-2.40%

General

Market Cap: $126.42M
Enterprise Value: $97.95M
Shares Outstanding: 36,230,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 32.68%
Operating Margin: -588.24%
Net Profit Margin: -691.81%
FCF Margin: -609.05%
ROA: -68.74%
ROE: 168.68%
ROIC: -1855.48%
Current Ratio: 0.86
Debt-to-Equity: -7.33
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 36.36
P/FCF: —
P/B: —
EV/EBITDA: -4.46

Growth

Rev 1Y: —
Rev 1Y Fwd Est: 363.65%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $3.39M
Gross Margin: 32.68%
Operating Expenses: $21.07M
Operating Income: -$19.97M
Net Profit: -$23.48M

Balance Sheet

Cash and Equivalents: $26.69M
Working Capital: -$4.72M
Total Assets: $34.16M
Net Debt: -$25.44M
Total Liabilities: $34.33M
Total Equity: -$170K

Cash Flow Statement (TTM)

Cash Flow from Operations: -$19.77M
Cash Flow from Investing: -$3.71M
Cash Flow from Financing: $47.26M
Free Cash Flow: -$20.67M
Capital Expenditures: $897K